The data were consistent with classic tumorigenesis genes and pathways of these cancers, indicating that expression of TGM3 on tumor cells may have be regulated by B cell and T cell activation linker proteins, thereby affecting the immune reaction, and promoting both immune and oncogenic pathways. The gene discussed is TGM3; the disease is neoplasm.